SynthesisBMC medical genomics2025
Tracking of multidrug-resistant pathogen clones in Ghana: a systematic review and meta-analysis.
Synthesis in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionAntimicrobial resistance (AMR) threatens effective antibiotic treatment. Multidrug-resistant (MDR) bacterial clones pose a particular challenge because they facilitate rapid resistance dissemination. Tracking dominant antibiotic-resistant clones in Ghana will inform targeted surveillance and control. This systematic review characterised prevalent MDR clones of priority pathogens isolated from humans, animals, and the environment in Ghana.
methodsA search of PubMed, Scopus, and Web of Science databases was conducted from inception to October 4, 2024, for studies reporting genetic characterisation of MDR clones from Ghana. The risk of bias in the included studies was evaluated using the Newcastle–Ottawa scale (NOS), and data analysis involved descriptive statistics and proportional meta-analysis.
resultsTwenty-five studies met the eligibility criteria, and 10 different MDR bacterial species were identified from human, animal, and environmental sources. The pooled prevalence of MDR bacteria was 53.4% (95% CI: 39.8–66.9). The dominant E. coli clones were ST155 (38.0%), ST617 (29.1%), and ST10 (11.1%). For K. pneumoniae, ST152 and ST17 were the main clones detected, each with a prevalence of 13.7%. ST39 was also present at 9.0%. The major S. pneumoniae clones were ST802 (18.5%), ST15111 (12.3%), and ST15448 (4.8%). ST152 (27.3%), ST121 (21.3%), and ST9 (14.3%) were predominant among the S. aureus isolates. The most prevalent Acinetobacter baumannii clone was ST231 (77.3%), followed by ST2145 (13.6%).
conclusionThis systematic review provided the first comprehensive overview of MDR clones that may be circulating in Ghana. The identification of high-risk clones, such as E. coli ST155 and S. aureus ST152, highlights the need for urgent public health interventions. Continued tracking using standardised WGS methodologies across diverse sources is crucial for guiding antimicrobial resistance containment in Ghana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.